US FDA could be set to join PIC/S from 2011
This article was originally published in SRA
The US Food and Drug Administration could be set to join next year the international Pharmaceutical Inspection Co-operation Scheme (PIC/S), which allows for constructive collaboration between various drug regulatory agencies on issues relating to good manufacturing practices1,2.
You may also be interested in...
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.